Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Sciences|January 16, 2020
Significance of 5-<i>S</i>-Cysteinyldopa as a Marker for MelanomaKazumasa Wakamatsu, Satoshi Fukushima, Akane Minagawa, et al.
The Journal of Dermatology|September 12, 2017
Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two casesJunji Kato, Tokimasa Hida, Toshiharu Yamashita, et al.
International Journal of Molecular Sciences|June 24, 2022
Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A ReviewYasuaki Tamura, Akira Ito, Kazumasa Wakamatsu, et al.
Japanese Journal of Clinical Oncology|October 23, 2015
Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanomaTakushi Shirai, Tasuku Sano, Fuminao Kamijo, et al.
International Journal of Clinical Oncology|June 1, 2022
Difference in immunohistochemical findings among anti-PD-L1 antibodies and their relationships with CD4+ and CD8+ T cells in Japanese melanoma patientsDaisuke Yoneta, Junji Kato, Takafumi Kamiya, et al.
Immunity, Inflammation and Disease|April 1, 2021
IL-13 modulates ∆Np63 levels causing altered expression of barrier- and inflammation-related molecules in human keratinocytes: A possible explanation for chronicity of atopic dermatitisTerufumi Kubo, Sayuri Sato, Tokimasa Hida, et al.
The Journal of Dermatology|April 28, 2021
Genetic analyses of a secondary poroma and trichoblastoma in a HRAS-mutated sebaceous nevusTomoyuki Minowa, Takafumi Kamiya, Tokimasa Hida, et al.
Pigment Cell & Melanoma Research|July 29, 2014
A melanocyte--melanoma precursor niche in sweat glands of volar skinNatsuko Okamoto, Takahiro Aoto, Hisashi Uhara, et al.
The Journal of Dermatology|March 14, 2021
Five-year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanomaHisashi Uhara, Yoshio Kiyohara, Jiro Uehara, et al.
Cancer Science|April 9, 2019
Long-term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanomaNaoya Yamazaki, Yoshio Kiyohara, Hisashi Uhara, et al.
Pageof 13